FAST vs SGMO · P/E 43, rev $7.55B vs rev $57.8M
Fastenal Company (FAST) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the FAST and SGMO stock pages for the full models.
Not investment advice.